--- title: Newsroom | Drug Discovery & Development description: Drug Discovery & Development | --- [![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/) - [Newsroom](https://news.lifesciencenewswire.com/newsroom) - [Back to the main site](https://lifesciencenewswire.com/) ![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1") # Newsroom #### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow") #### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg) ![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg) ### Choose a Category - [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture) - [AI (1)](https://news.lifesciencenewswire.com/newsroom/tag/ai) - [Analytical Chemistry (42)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry) - [Biomanufacturing (35)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing) - [biopharma (21)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma) - [Bioprocessing (16)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing) - [Biotechnology (251)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology) - [Cell Culture (10)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture) - [Clinical Diagnostics (36)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) - [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research) - [Clinical Research & Trials (114)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) - [Computing & Technology (62)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it) - [Corporate, Finance & Investor (287)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) - [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19) - [Diagnostics & Hospital Laboratory (35)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory) - [Digital Pathology (1)](https://news.lifesciencenewswire.com/newsroom/tag/digital-pathology) - [Drug Discovery & Development (152)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) - [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment) - [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients) - [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage) - [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry) - [General Laboratory (58)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory) - [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science) - [Healthcare (135)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare) - [Hospital Management (7)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management) - [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science) - [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing) - [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science) - [Medical Devices & Technology (26)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) - [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control) - [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging) - [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech) - [Omics & Genetics (87)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics) - [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology) - [Pharma (118)](https://news.lifesciencenewswire.com/newsroom/tag/pharma) - [Pharmacy (5)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy) - [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research) - [Veterinary (6)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary) - [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water) See all ### Subscribe to Email Updates Categories: [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) #### [Qinecsa selected as technology partner for Africa’s new continent-wide medicines safety platform](https://news.lifesciencenewswire.com/newsroom/qinecsa-selected-as-technology-partner-for-africas-new-continent-wide-medicines-safety-platform) September 10, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/qinecsa-selected-as-technology-partner-for-africas-new-continent-wide-medicines-safety-platform) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/qinecsa-selected-as-technology-partner-for-africas-new-continent-wide-medicines-safety-platform#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Sep 10, 2026, 11:00:02 AM - [Tweet](https://twitter.com/share) Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma) #### [ENPICOM Platform to accelerate antibody discovery for Evolved Therapeutics](https://news.lifesciencenewswire.com/newsroom/enpicom-platform-to-accelerate-antibody-discovery-for-evolved-therapeutics) September 1, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/enpicom-platform-to-accelerate-antibody-discovery-for-evolved-therapeutics) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/enpicom-platform-to-accelerate-antibody-discovery-for-evolved-therapeutics#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Sep 1, 2026, 2:00:01 PM - [Tweet](https://twitter.com/share) Categories: [Omics & Genetics](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics), [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [Danish 3D cell culture company Celvivo secures USD 6.6 million in funding and appoints new CEO to lead next growth phase](https://news.lifesciencenewswire.com/newsroom/danish-3d-cell-culture-company-celvivo-secures-usd-6.6-million-in-funding-and-appoints-new-ceo-to-lead-next-growth-phase-1) August 27, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/danish-3d-cell-culture-company-celvivo-secures-usd-6.6-million-in-funding-and-appoints-new-ceo-to-lead-next-growth-phase-1) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/danish-3d-cell-culture-company-celvivo-secures-usd-6.6-million-in-funding-and-appoints-new-ceo-to-lead-next-growth-phase-1#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Aug 27, 2026, 12:30:00 PM - [Tweet](https://twitter.com/share) Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) #### [Inceptua Group Selected to Manage TikoMed’s Named Patient Program for Investigational Therapy ILB® in Amyotrophic Lateral Sclerosis (ALS)](https://news.lifesciencenewswire.com/newsroom/inceptua-group-selected-to-manage-tikomeds-named-patient-program-for-investigational-therapy-ilb-in-amyotrophic-lateral-sclerosis-als) August 26, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/inceptua-group-selected-to-manage-tikomeds-named-patient-program-for-investigational-therapy-ilb-in-amyotrophic-lateral-sclerosis-als) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/inceptua-group-selected-to-manage-tikomeds-named-patient-program-for-investigational-therapy-ilb-in-amyotrophic-lateral-sclerosis-als#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Aug 26, 2026, 12:00:01 PM - [Tweet](https://twitter.com/share) Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) #### [ARScience Biotherapeutics Initiates Technology Transfer for Commercial Manufacturing of Low Dose Interleukin-2](https://news.lifesciencenewswire.com/newsroom/arscience-biotherapeutics-initiates-technology-transfer-for-commercial-manufacturing-of-low-dose-interleukin-2) July 22, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/arscience-biotherapeutics-initiates-technology-transfer-for-commercial-manufacturing-of-low-dose-interleukin-2) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/arscience-biotherapeutics-initiates-technology-transfer-for-commercial-manufacturing-of-low-dose-interleukin-2#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jul 22, 2026, 12:15:00 PM - [Tweet](https://twitter.com/share) Categories: [Omics & Genetics](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics), [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [biopharma](https://news.lifesciencenewswire.com/newsroom/tag/biopharma) #### [Alithea Genomics Launches Early Access Program for MERCURIUS™ 1536 DRUG-seq, Bringing Transcriptomics to Compound Screening Scale](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale) June 16, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jun 16, 2026, 1:01:59 PM - [Tweet](https://twitter.com/share) Categories: [Diagnostics & Hospital Laboratory](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials), [Clinical Diagnostics](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) #### [CellCarta and Sonic Healthcare Establish Strategic Partnership to Commercialize Companion Diagnostics Through Lab Network](https://news.lifesciencenewswire.com/newsroom/cellcarta-and-sonic-healthcare-establish-strategic-partnership-to-commercialize-companion-diagnostics-through-lab-network) May 27, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cellcarta-and-sonic-healthcare-establish-strategic-partnership-to-commercialize-companion-diagnostics-through-lab-network) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/cellcarta-and-sonic-healthcare-establish-strategic-partnership-to-commercialize-companion-diagnostics-through-lab-network#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on May 27, 2026, 4:14:48 PM - [Tweet](https://twitter.com/share) Categories: [Biomanufacturing](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing), [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) #### [Cirena has entered into a licensing agreement with Agilent Technologies, Inc. for long RNA purification technology.](https://news.lifesciencenewswire.com/newsroom/cirena-has-entered-into-a-licensing-agreement-with-agilent-technologies-inc.-for-long-rna-purification-technology) May 7, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cirena-has-entered-into-a-licensing-agreement-with-agilent-technologies-inc.-for-long-rna-purification-technology) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/cirena-has-entered-into-a-licensing-agreement-with-agilent-technologies-inc.-for-long-rna-purification-technology#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on May 7, 2026, 1:04:00 PM - [Tweet](https://twitter.com/share) Categories: [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [Axithra appoints Lars Kongsbak as CEO to lead next phase of growth and series A financing](https://news.lifesciencenewswire.com/newsroom/axithra-appoints-lars-kongsbak-as-ceo-to-lead-next-phase-of-growth-and-series-a-financing) April 24, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/axithra-appoints-lars-kongsbak-as-ceo-to-lead-next-phase-of-growth-and-series-a-financing) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/axithra-appoints-lars-kongsbak-as-ceo-to-lead-next-phase-of-growth-and-series-a-financing#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Apr 24, 2026, 9:08:56 AM - [Tweet](https://twitter.com/share) [All posts](https://news.lifesciencenewswire.com/newsroom/all) [Next](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development/page/2) ##### Browse more news ## Recent releases #### [Ceryx Medical appoints Professor Zaheer Yousef OBE as Chief Medical Officer](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-appoints-professor-zaheer-yousef-obe-as-chief-medical-officer) September 21, 2026 Leading heart failure cardiologist and RSA-Pace principal investigator joins as the company prepares its next clinical study Ceryx Medical (Ceryx), th... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-appoints-professor-zaheer-yousef-obe-as-chief-medical-officer) #### [Qinecsa selected as technology partner for Africa’s new continent-wide medicines safety platform](https://news.lifesciencenewswire.com/newsroom/qinecsa-selected-as-technology-partner-for-africas-new-continent-wide-medicines-safety-platform) September 10, 2026 The global pharmacovigilance specialist will help drive one of Africa’s most comprehensive medicines safety initiatives. Qinecsa, the global pharmacov... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/qinecsa-selected-as-technology-partner-for-africas-new-continent-wide-medicines-safety-platform) #### [Sakura Finetek Europe launches Sakura Pathology Network](https://news.lifesciencenewswire.com/newsroom/sakura-finetek-europe-launches-sakura-pathology-network) September 10, 2026 A new initiative to connect and empower early-career pathologists across Europe Sakura Finetek Europe today announced the launch of the Sakura Patholo... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/sakura-finetek-europe-launches-sakura-pathology-network) ![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse") Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225  #### Useful information - [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/) - [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions) - [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)